Cochrane DCIG

@CochraneDCIG

Cochrane Dementia and Cognitive Improvement Group promoting high quality evidence for all. Retweets are not necessarily endorsements.

England, United Kingdom
dementia.cochrane.org/about-us
Joined October 2016
4 Photos and videos Photos and videos

Tweets

You blocked @CochraneDCIG

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @CochraneDCIG

  1. Retweeted
    Apr 3

    from - Reminiscence Therapy for Dementia Looking at the discussion of memories and past experiences using tangible prompts such as photographs or music to evoke memories and stimulate conversation.

    2 retweets 3 likes
    Undo
  2. Retweeted
    Apr 3

    Congrats to , and colleagues for publishing the update of their on withdrawal of long-term for with , published with .

    3 retweets 2 likes
    Undo
  3. Apr 3

    Reminiscence therapy for people with dementia: does it help and what benefits are there? New review looking at the evidence

    Undo
  4. Retweeted
    Mar 29

    We're busy planning ways to extend the conversations at Cochrane's next global health conference far . Increasing virtual participation is just one of the ways we're making this event :

    Just had a fab meeting with from about taking in September. We’ll be joining >1,000 people in Edinburgh for the 2018 Cochrane Colloquium which is a event this year. Look out for announcements soon!
    5 retweets 7 likes
    Undo
  5. Mar 28

    Does looking back benefit looking forward? Reminiscence therapy for dementia: what is the evidence?

    2 retweets 1 like
    Undo
  6. Mar 26

    Florbetapir is an amyloid ligand used in positron emission tomography (PET) proposed as a way of detecting those who have MCI who will progress to dementia. What is the evidence to use this ligand in PET as a routine test? how effective given the costs?

    Undo
  7. Mar 26

    Is using florbetaben, an amyloid ligand, in PET scanning, accurate in predicting the people with MCI who will progress to develop a dementia? how sensitive and specific is the test? Our review:

    1 like
    Undo
  8. Mar 26

    Flutemetamol is an amyloid ligand used in positron emission tomography (PET) to detect amyloid load. what is the evidence for it in predicting those who have MCI who will convert to a dementia?

    Undo
  9. Mar 18

    What is the evidence for measuring CSF tau and the CSF tau/ABeta ratio in MCI to predict development of AD or other dementias? More importantly, what are the reference points? See our review:

    2 retweets 4 likes
    Undo
  10. Mar 12

    Review of the accuracy of CSF t-tau (total tau), CSF p-tau (phosphorlyated tau) and the ratios of CSF t-tau/ A Beta and CSF p-tau/Abeta in predicting those who would convert from MCI syndrome to Alzheimer’s disease or other dementia: What is the evidence?

    1 retweet 1 like
    Undo
  11. Retweeted
    Mar 8

    Newest in the series of of out now Diagnostic research in older people From Y Takwoingi &

    3 retweets 5 likes
    Undo
  12. Mar 6

    Florbetapir is an amyloid ligand used in positron emission tomography (PET) proposed as a way of detecting those who have MCI who will progress to dementia. What is the evidence to use this ligand in PET as a routine test? how effective given the costs?

    Undo
  13. Mar 6

    Flutemetamol is an amyloid ligand used in positron emission tomography (PET) to detect amyloid load. what is the evidence for it in predicting those who have MCI who will convert to a dementia?

    1 retweet 1 like
    Undo
  14. Mar 6

    Is using florbetaben, an amyloid ligand, in PET scanning, accurate in predicting the people with MCI who will progress to develop a dementia? how sensitive and specific is the test? Our review:

    1 retweet 2 likes
    Undo
  15. Mar 5

    What is the evidence for Trazodone, Melatonin and Ramelteon helping sleep disturbances in people with dementia? Our review:

    10 retweets 9 likes
    Undo
  16. Feb 28

    Reduced nocturnal sleep, sleep fragmentation, nocturnal wandering, daytime sleepiness are common in dementia: is there high quality evidence for treatments used? Our review:

    4 retweets 1 like
    Undo
  17. Feb 24

    Do personally tailored activities improve psychosocial outcomes for people with dementia in long term care? New review looks at the evidence and discusses the findings:

    1 retweet 4 likes
    Undo
  18. Feb 21

    Do personally tailored activities improve psychosocial outcomes for people with dementia in long term care? New review looks at the evidence and discusses the findings:

    1 retweet 4 likes
    Undo
  19. Jan 30

    why don't you, switch of the TVset and do something less boring instead...

    Rather than flick through Twitter & Facebook, why not contribute to medical research? Join us for . You'll be introduced to 3 projects that don't req. prior knowledge. Go on, we dare you to join us & make a difference! Read more:
    1 retweet 2 likes
    Undo
  20. Jan 4

    'NICE' to see our reviews on dementia diagnosis featured, watch this space for reviews on AD-8 and mini-cog

    We’re updating our guideline on dementia and today we’ve published draft recommendations for public consultation. Let us know what you think at:
    7 retweets 9 likes
    Undo

@CochraneDCIG hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·